Legis Daily

Encouraging Innovative Benefit Design to Lower Costs for Seniors Act

USA116th CongressS-3013| Senate 
| Updated: 12/10/2019
Patrick Toomey

Patrick Toomey

Republican Senator

Pennsylvania

Cosponsors (2)
John Kennedy (Republican)Mike Crapo (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act This bill allows prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to offer additional plans in a region. Specifically, the Centers for Medicare & Medicaid Services (CMS) must update guidance to allow PDP sponsors to offer up to four plans in a region; the CMS may also set a greater limit, as appropriate. PDP sponsors may offer up to two additional plans beyond this limit if the PDP sponsor ensures that, under at least one of the plans, pharmacy benefit managers do not receive any remuneration unless at least 10% of price reductions received from drug manufacturers are reflected at the point-of-sale or otherwise used to reduce beneficiary cost-sharing.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 10, 2019
Introduced in Senate
Dec 10, 2019
Read twice and referred to the Committee on Finance.
  • December 10, 2019
    Introduced in Senate


  • December 10, 2019
    Read twice and referred to the Committee on Finance.

Health

Related Bills

  • S 116-3129: Lower Costs, More Cures Act of 2019
  • HR 116-19: Lower Costs, More Cures Act of 2019
Government information and archivesHealth care costs and insuranceHealth care coverage and accessInsurance industry and regulationMedicarePrescription drugs

Encouraging Innovative Benefit Design to Lower Costs for Seniors Act

USA116th CongressS-3013| Senate 
| Updated: 12/10/2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act This bill allows prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to offer additional plans in a region. Specifically, the Centers for Medicare & Medicaid Services (CMS) must update guidance to allow PDP sponsors to offer up to four plans in a region; the CMS may also set a greater limit, as appropriate. PDP sponsors may offer up to two additional plans beyond this limit if the PDP sponsor ensures that, under at least one of the plans, pharmacy benefit managers do not receive any remuneration unless at least 10% of price reductions received from drug manufacturers are reflected at the point-of-sale or otherwise used to reduce beneficiary cost-sharing.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 10, 2019
Introduced in Senate
Dec 10, 2019
Read twice and referred to the Committee on Finance.
  • December 10, 2019
    Introduced in Senate


  • December 10, 2019
    Read twice and referred to the Committee on Finance.
Patrick Toomey

Patrick Toomey

Republican Senator

Pennsylvania

Cosponsors (2)
John Kennedy (Republican)Mike Crapo (Republican)

Finance Committee

Health

Related Bills

  • S 116-3129: Lower Costs, More Cures Act of 2019
  • HR 116-19: Lower Costs, More Cures Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Government information and archivesHealth care costs and insuranceHealth care coverage and accessInsurance industry and regulationMedicarePrescription drugs